Skip to content
  1. EMEA Innovative Medicine /
  2. Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Resulted in Durable Protection Against Breakthrough Infection, Hospitalisation, and Intensive Care Unit Admission in the United States

Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Resulted in Durable Protection Against Breakthrough Infection, Hospitalisation, and Intensive Care Unit Admission in the United States

Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Resulted in Durable Protection Against Breakthrough Infection, Hospitalisation, and Intensive Care Unit Admission in the United States